Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Rxo (RXO) Leases (2021 - 2025)

Historic Leases for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $238.0 million.

  • Rxo's Leases fell 1376.81% to $238.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $238.0 million, marking a year-over-year decrease of 1376.81%. This contributed to the annual value of $238.0 million for FY2025, which is 1376.81% down from last year.
  • Per Rxo's latest filing, its Leases stood at $238.0 million for Q4 2025, which was down 1376.81% from $254.0 million recorded in Q3 2025.
  • Rxo's 5-year Leases high stood at $333.0 million for Q3 2024, and its period low was $128.0 million during Q4 2021.
  • Moreover, its 5-year median value for Leases was $200.0 million (2024), whereas its average is $210.0 million.
  • As far as peak fluctuations go, Rxo's Leases skyrocketed by 9248.55% in 2024, and later plummeted by 2372.37% in 2025.
  • Rxo's Leases (Quarter) stood at $128.0 million in 2021, then grew by 24.22% to $159.0 million in 2022, then increased by 22.64% to $195.0 million in 2023, then skyrocketed by 41.54% to $276.0 million in 2024, then fell by 13.77% to $238.0 million in 2025.
  • Its last three reported values are $238.0 million in Q4 2025, $254.0 million for Q3 2025, and $250.0 million during Q2 2025.